[Associations between plasma n-3 polyunsaturated fatty acids and gestational diabetes mellitus in the second trimester]

Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Mar 6;56(3):312-321. doi: 10.3760/cma.j.cn112150-20210428-00422.
[Article in Chinese]

Abstract

Objective: To examine the associations between plasma n-3 polyunsaturated fatty acids (PUFAs) in the second trimester and gestational diabetes mellitus (GDM) among Chinese pregnant women. Methods: Based on data from the Tongji-Shuangliu Birth Cohort enrolled from 2017 to 2019 in the Shuangliu Maternal and Child Health Hospital, it conducted a case-control study among 269 GDM cases who were diagnosed by 75 g oral glucose tolerance test, and 538 non-GDM controls matched at a 1∶2 ratio on maternal age and gestational weeks. The age range of the 807 women was 18-40 years. Fasting plasma n-3 PUFAs were determined by gas chromatography-mass spectrometry in the second trimester (24-28 weeks). Participants were categorized into quartiles (Q1-Q4) of plasma n-3 PUFAs based on distributions in the control group. Conditional logistic regression models were applied to estimate the associations between plasma n-3 PUFAs and GDM. Results: The median (interquartile) relative concentrations of plasma n-3 PUFA C22∶5n-3 was significantly lower in women with GDM 0.87 (0.72, 1.07) compared with women without GDM 0.94 (0.75, 1.19)(P=0.001). Plasma n-3 PUFA C22∶5n-3 was inversely associated with GDM, with an OR (95%CI) of 0.75 (0.62-0.90) for each SD increase of relative concentration. Compared with the Q1 group, the OR values and 95%CIs of Q2, Q3, and Q4 groups were 0.97 (0.62-1.51), 0.72 (0.45-1.15), and 0.54 (0.32-0.90), respectively (Ptrend<0.05). However, there were no significant associations of C18∶3n-3, C20∶5n-3, C22∶6n-3, and total n-3 PUFAs with GDM. Conclusion: Plasma n-3 PUFA C22∶5n-3 was inversely associated with GDM during the second trimester.

目的: 探讨我国孕妇的孕中期血浆n-3多不饱和脂肪酸(polyunsaturated fatty acids,PUFAs)相对浓度与妊娠期糖尿病(gestational diabetes mellitus,GDM)的关联。 方法: 基于同济-双流出生队列,选择2017年至2019年在成都市双流区妇幼保健院进行产前检查,并通过75 g口服葡萄糖耐量试验确诊GDM的269例患者为病例组,根据基线孕周和年龄进行1∶2匹配,选取538名无GDM的孕妇作为对照组。纳入研究的807名孕妇年龄范围为18~40岁。通过气相色谱-质谱联用方法定量检测病例组和对照组孕中期(24~28周)空腹血浆n-3 PUFAs的相对浓度。根据对照组血浆n-3 PUFAs相对浓度的四分位数将研究对象分为4组(Q1~Q4),采用条件logistic回归模型分析孕中期血浆n-3 PUFAs与GDM之间的关联。 结果: GDM与非GDM孕妇血浆n-3 PUFAs中C22∶5n-3的相对浓度中位数(四分位数间距)分别为0.87(0.72,1.07)和0.94(0.75,1.19),P=0.001。条件logistic回归模型结果显示,孕中期血浆C22∶5n-3与GDM的患病风险呈负相关关联,相对浓度每增加1个标准差对应的OR值(95%CI)为0.75(0.62~0.90);与Q1组相比,Q2、Q3、Q4组的OR(95%CI)值分别为0.97(0.62~1.51)、0.72(0.45~1.15)和0.54(0.32~0.90),P趋势<0.05。未发现其他n-3 PUFAs(C18∶3n-3、C20∶5n-3、C22∶6n-3和总n-3 PUFAs)与GDM之间存在显著性关联。 结论: 孕中期血浆n-3 PUFA C22∶5n-3与妊娠期糖尿病的患病风险可能存在负关联。.

MeSH terms

  • Case-Control Studies
  • Child
  • Diabetes, Gestational*
  • Fatty Acids, Unsaturated
  • Female
  • Glucose Tolerance Test
  • Humans
  • Pregnancy
  • Pregnancy Trimester, Second

Substances

  • Fatty Acids, Unsaturated